Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 3/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.36 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.36 |
| ▸ | HRH1 | P35367 | 2/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL29123031 | 0.80 | MTNR1A (0.35) | MTORRAB9AGRM7 | |
| Acetic Acid SCHEMBL8076703 | 0.74 | MIF (0.39) | MIFTSHRALOX15HRH1HTR2A | |
| SCHEMBL28568357 | 0.74 | MTOR (0.69) | MTORRAB9AGRM7CYP3A4TSHR | |
| SCHEMBL8728326 | 0.72 | MIF (0.37) | MIFGRIN1GRIN2A | |
| Isopropylbenzene SCHEMBL28259979 | 0.69 | TAAR1 (0.47) | ALOX15GRIN1GRIN2AHRH1HTR2A | |
| SCHEMBL10537184 | 0.68 | MTOR (0.40) | MTORRAB9AGRM7CYP3A4TSHR | |
| Isopropylbenzene SCHEMBL28209871 | 0.67 | TAAR1 (0.45) | RAB9AALOX15GRIN1GRIN2AHRH1 | |
| Hydrochloric Acid SCHEMBL7126952 | 0.67 | ALOX15 (0.42) | MTORRAB9AGRM7CYP3A4TSHR | |
| SCHEMBL4204090 | 0.67 | KCNH2 (0.65) | CYP3A4ALOX15GRIN1GRIN2AHRH1 | |
| SCHEMBL21896763 | 0.65 | KDM4E (0.66) | GRIN1GRIN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110282031-A1 | A1 ADENOSINE RECEPTOR DIAGNOSTIC PROBES | WILSON CONSTANCE N (US) | 2011-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282031-A1 | A1 ADENOSINE RECEPTOR DIAGNOSTIC PROBES | ADORA1, ADORA3, ADORA2A | MIF 3477/4885MTOR 4698/4885RAB9A 2161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.